Announces Appointment of New Non-Executive Director
London, Dec 10, 2012 AEST (ABN Newswire) - Healthcare specialist Westhouse Medical Services Plc (
5WM:FRA) today announces the appointment of Mr Kevin Riches as Non-Executive Director. Kevin has over 25 years experience in start up and mature businesses, both large and small.
The sectors have ranged from IT and communications through environmental and finance to PFI in hospitals and Education.
Kevin has a proven track record as a change agent and has an excellent, mature network of business leaders, contacts and partners. Recent successful business engagements include SpinVox, Dennis Publishing, Carteme, Phones 4 U, PRS and PTS Consulting.
He is a Director and Shareholder at European American Capital, Carteme, Applied Cytometry, Plasma Europe and at Waterbridge Capital
Kevin is passionate about value creation, often at a consumer level, usually delivered via B2B relationships.
Westhouse is currently developing a number of medical devices, including BreastCheck - a new low-cost, non-invasive breast cancer screening product which can act as a precursor to mammogram scanning. BreastCheck is due for launch in 2013.
Westhouse recently acquired from US-listed Sunridge International via. Sunridge's subsidiary, Ophthalmic International Inc, a glaucoma procedure called PNT, which could revolutionise the way glaucoma is treated globally.
WESTHOUSE MEDICAL SERVICES PLC
SYMBOL: 5WM
WKN: A1JKH7
ISIN: GB00B6YWDK49
SEDOL: B6YWDK4
~ends~
Contact
For press information, contact:
Global Press and Public Relations:
Gabriel Luca
Wedgewood Communications
60 Madison Avenue
Suite 1212
New York
NY 10010 USA
Tel: +1 646 592 7559
westhouse@wwprnews.com
| ||
|
